Taken together, these findings suggest that BRD7 may promote tumor cell death by inhibiting the repair of radiotherapy-induced DSBs, which may be a potential mechanism through which BRD7 enhances the radiosensitivity of NPC cells. The gene discussed is BRD7; the disease is neoplasm.